Concepedia

Mark T. Baillie

MT

Statistics

Publications

5

Citations

137

H-Index

5

Active since

2000

Affiliations

Emory University(Current)

University of Washington

Veterans Health Administration

Mark T. Baillie is an author at Emory University specializing in pharmacology, medicine, and enantioselective synthesis.

ORCID

Publications per year

2000–2016

5

Publications

5

Determination of Free and Total Cortisol in Plasma and Urine by Liquid Chromatography-Tandem Mass Spectrometry

Weili Huang, Thomas F. Kalhorn, Mark T. Baillie et al. · Therapeutic Drug Monitoring · 2007 · 38 citations

, , +17

Novel Synthesis and Biological Evaluation of Enigmols as Therapeutic Agents for Treating Prostate Cancer

Ethel C. Garnier‐Amblard, Suzanne G. Mays, Richard F. Arrendale et al. · ACS Medicinal Chemistry Letters · 2011 · 34 citations

, , +9

Persistent Inhibition of CYP3A4 by Ketoconazole in Modified Caco-2 Cells

Megan Gibbs, Mark T. Baillie, Danny D. Shen et al. · Pharmaceutical Research · 2000 · 28 citations

, , +7

Discovery of a Fluorinated Enigmol Analog with Enhanced <i>in Vivo</i> Pharmacokinetic and Anti-Tumor Properties

Eric J Miller, Suzanne G. Mays, Mark T. Baillie et al. · ACS Medicinal Chemistry Letters · 2016 · 22 citations

, , +13

An efficient asymmetric synthesis of enigmols (1-deoxy-5-hydroxysphingoid bases), an important class of bioactive lipid modulators

Anatoliy Bushnev, Mark T. Baillie, Jason J. Holt et al. · ARKIVOC · 2010 · 15 citations · Full text

, , +5

1–5 of 5